Novartis to Donate Drug in Coronavirus Fight
March 20 2020 - 1:00PM
Dow Jones News
By Giulia Petroni
Novartis AG said Friday that it would donate up to 130 million
doses of generic hydroxychloroquine by the end of May to support
the global response to the coronavirus pandemic.
The Swiss drug maker said hydroxychloroquine and a related drug,
chloroquine, are currently being evaluated in clinical trials for
the treatment of the virus. The company is exploring the
possibility of increasing supply to meet global demand.
Novartis said its division Sandoz, which focuses on generic
pharmaceuticals and biosimilars, holds a registration for
hydroxychloroquine in the U.S. and will therefore pursue regulatory
approval from the Food and Drug Administration and the European
Medicine Agency.
It added that it would collaborate with the World Health
Organization to determine the best distribution of the medicine on
a global scale.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
March 20, 2020 12:45 ET (16:45 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024
